PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Debate Heats Up Over Reference Pricing Plan

The Quest to Measure Drug Effectiveness

Biosensors in Pharma: A Dose of Optimism

Gene Therapy
R. Jude Samulski: Gene Therapy’s Guiding Force
Chronicling the career “trek” of gene therapy visionary R. Jude Samulski, whose work uncovering the mysteries of adeno-associated virus while navigating the field’s reputational turbulence continues to fuel new hopes for AAV vector technology in transforming therapies for rare disease.
... /Read more/
Advertisement
Launching Medical Devices in the Japanese Market - How to navigate regulatory and reimbursement approval
On Demand
Digital Strategy
A Meaningful Customer-Centric Digital Strategy
Data is fast becoming the most valuable commodity known to man. As an infinite resource with evolving applications, the pace at which organizations can acquire, manage the flow of, and leverage data is becoming a crucial factor in the future success of businesses, write Pamela Walker and Tom Murdoch.
... /Read more/
Advertisement
Japan Oncology Market – Best in Class Practices for Advancing Patient Outcomes
On Demand
Patient Centricity
IDMP: Making Patients the Priority in 2020
2019 saw progress towards ISO IDMP data standards implementation, but making patients central to project focus must remain a priority, says Frits Stulp.
... /Read more/
Calendar
/ Compliance Monitoring, Audit & Risk Oversight — 2/10-2/12 /
 
/ Life Sciences Compliance Congress Asia — 2/27-2/28 /
 
 
 

Advertisement
Order-To-Cash Management Fundamentals to Increase Profitability and Reduce Risk
On Demand

Advertisement
A Modern Approach to Global Growth & Compliance in Life Sciences: A Story of Digitalization at Boehringer Ingelheim
On Demand

 
Pipeline Report
Pharm Exec’s 2020 Pipeline Report
Our Annual Pipeline Report examines six key areas of biopharma R&D—a mix of emerging and maturing—where promising research efforts are now beginning to pay dividends, as novel advances in science usher in new treatment approaches and curative therapies.
... /Read more/
The Pharm Exec Podcast: Episode 45
Sponsored by Fingerpaint
Getting Drug Approval Through FDA LPAD
William Lewis, chairman and CEO of Insmed talks about the approval of the company’s drug Arikayce through the FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs, some ideas that he spoke about on the recent NORD panel about innovative and ethical partnerships, and Insmed’s pipeline and progress.
... /Read more/

 
update my profile / advertise with us / print & digital subscribe / visit pharmexec.com